N-((4-CHLOROPHENYL)METHYL)-4-HYDROXY-6-(3-HYDROXYPROP-1-YN-1-YL)QUINOLINE-3-CARBOXAMIDE
UNII BR9VDR3HHB
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((4-chlorophenyl)methyl)-4-hydroxy-6-(3-hydroxyprop-1-yn-1-yl)quinoline-3-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BR9VDR3HHB.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 228726-59-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H15ClN2O3 LHCASPYXLIAHLU-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((4-chlorophenyl)methyl)-4-hydroxy-6-(3-hydroxyprop-1-yn-1-yl)quinoline-3-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.